Scott Egon Eggener

Scott Eggener practices at The University of Chicago Medical Center in Chicago, Illinois.

Scott Eggener's NPI, 1548440027, was assigned on November 13, 2007. Scott Eggener graduated from Stanford University School Of Medicine in 1999. Scott Eggener holds Illinois license 036106852.

Scott Eggener's primary practice is The University of Chicago Medical Center, at 5841 S Maryland Ave, Chicago, IL 60637 in Cook County. The practice phone is (773) 702-1530.

Scott Eggener's primary practice is The University of Chicago Medical Center in Chicago, Illinois. Scott Eggener is also affiliated with University of Chicago Medical Center. The medical group on file is UChicago Medicine Physicians. Dmand AI also links Scott Eggener to 2 more hospitals, 2 medical groups and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Scott Eggener practices, 4 sites in all. Vendor and product names are available with a free account.

Urology is Scott Eggener's primary specialty in the NPI Registry, under taxonomy code 208800000X. Scott Eggener is board certified in urology by the American Board of Urology. Dmand AI has Scott Eggener's licenses on file in 4 states: Illinois, Indiana, North Dakota and New York.

Dmand AI lists enlarged prostate, erectile dysfunction, kidney cysts, kidney removal surgery, prostate cancer, prostate surgery, urinary endoscopy and urine flow blockage among the conditions Scott Eggener treats.

CMS data shows 747 Medicare services from Scott Eggener across 12 procedure codes in 2024, for 495 Medicare patients. Medicare paid $105,544 for them.

CMS counts 495 Medicare patients who saw Scott Eggener in 2024. The largest group is 65 to 74, with 320 patients. 75% of them have high cholesterol, and 73% have cancer. 9% are also on Medicaid. Their average risk score is 1.46, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Scott Eggener's median patient age at 70, with 8% women.

In 2024, Scott Eggener wrote 24 Medicare Part D claims for 12 patients. 100% of them were for generic drugs. CMS names the drug for 15 of them, across 1 drug with 11 or more claims each, at $324 in total drug cost. In 2023, CMS named 23 claims across 1 drug.

Scott Eggener accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Scott Eggener as offering telehealth.

Prostate resection: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 242 papers to Scott Eggener, published from 2006 to 2025. 2019 was the busiest year, with 14. The most frequent topics are Prostatic Neoplasms, Prostatectomy and Prostate-Specific Antigen. Scott Eggener has published most often in J Urol. Scott Eggener's most frequent co-authors are Tatjana Antic, MD, Matthew R. Cooperberg, MD and James A. Eastham, MD.

Dmand AI links Scott Eggener to 6 clinical trials. 1 is still active or recruiting. Conditions studied include Prostatic Neoplasms and Prostatic Diseases. University of Chicago sponsors the most, 3.

CMS Open Payments shows 157 general payments to Scott Eggener from 14 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 65% of the total. Janssen Pharmaceuticals, Inc paid the most, $157,249.

Dmand AI lists 1 award for Scott Eggener, most recently CMS Stage 1 EHR in 2013.

Scott Eggener graduated from Stanford University School Of Medicine in 1999.

Scott Eggener is in network with 11 carriers, including Elevance, Aetna and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 9. Check the plan with the practice before a visit.